You are here

Lenvatinib

Eisai says its new thyroid cancer drug is a sure blockbuster

Fierce Biotech

Thu, 02/12/15 - 09:05 am

Eisai's Thyroid Cancer Drug Gets FDA Priority Review

Drug Discovery and Development

Thu, 10/16/14 - 09:13 am

Japan’s Eisai Steps Up Push in Cancer Drugs

WSJ Online

Mon, 08/18/14 - 09:32 am

Lenvatinib Phase III Results Show Significant Improvement In Progression-Free Survival In Patients With Radioiodine-Refractory Differentiated Thyroid Cancer

Pipeline Review

Sun, 06/1/14 - 11:47 am

Eisai readies applications for thyroid cancer drug after SFJ delivers PhIII success

Fierce Biotech

Tue, 02/4/14 - 07:05 pm

SFJ Pharmaceuticals

Eisai gets orphan drug status for Lenvatinib

Marketwatch

Fri, 02/15/13 - 11:09 am